Le Point International: Cancer vaccines: why BioNTech is betting on the UK
Thomas Roulet, Associate Professor in Organisation Theory and Deputy Director of the MBA programme at Cambridge Judge Business School, is quoted in this article mentioning AstraZeneca's anti-Covid19 vaccine. "This vaccine showed this country's ability to create ecosystems that combine an…
Carryover co-operation
Sir Mene Pangalos of AstraZeneca, in a Cambridge Judge interview, urges continuation of the 'exceptional' collaboration between industry, academia, government and regulators that led to rapid development of COVID-19 vaccines. Sir Mene Pangalos The "exceptional" collaboration between the pharmaceutical industry,…
Forbes: The vaccine reputation war will only leave one winner: the virus
Dr Thomas Roulet, University Senior Lecturer in Organisation Theory at Cambridge Judge Business School, writes about the vaccine reputation war. He says that audiences seek consistency, and such bias can easily cloud their judgment on a large scale. “Whatever the…
Forbes: Playing blame games is not only unethical, it is also the wrong way out of the Covid-19 mess
Dr Thomas Roulet, University Senior Lecturer in Organisation Theory at Cambridge Judge Business School, discusses what makes blame games possible and why they backfire, taking the example of the efforts to shift responsibilities for the slow Covid-19 vaccine rollout. “By…
Forbes: It’s not just the anti-vaxxers: Why are so many people wary of Covid-19 vaccines?
Sunita Sah, KPMG Professor of Management Studies at Cambridge Judge Business School, discusses the reasons why people mistrust the Covid-19 vaccines and what could be done to overcome this. “Public endorsements of Covid-19 vaccines from trusted leaders from the same…